Related Experiment Video
Updated: May 7, 2026

07:55
A Multi-Parametric Islet Perifusion System within a Microfluidic Perifusion Device
Published on: January 26, 2010
A microfluidic device designed to induce media flow throughout pancreatic islets while limiting shear-induced damage
Pamuditha N Silva1, Brenda J Green, Svetlana M Altamentova
1Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, Ontario M5S 3G9, Canada. jon.rocheleau@utoronto.ca.
Lab on a Chip
|September 24, 2013
Summary
This study introduces a novel microfluidic device that improves endothelial cell (EC) morphology in pancreatic islets. This innovation supports islet health for research and enhances potential for transplantation in diabetes treatment.
Area of Science:
- Endocrinology
- Bioengineering
- Cell Biology
Background:
- Pancreatic islets require vascularization by endothelial cells (ECs) for glucose sensing and hormone secretion.
- In vitro culture leads to EC loss, hindering study of islet cell interactions and limiting transplant efficacy.
- Previous microfluidic approaches showed benefits but also caused shear-induced damage to peripheral islet cells.
Purpose of the Study:
- To develop a microfluidic device that preserves islet endothelial cell morphology and function in vitro.
- To create a platform for studying the interaction between pancreatic beta cells and ECs.
- To optimize islet preparation for transplantation.
Main Methods:
- Designed a microfluidic device with cup-shaped nozzles to trap islets, controlling flow velocity.
- Cultured islets within the device to assess endothelial cell morphology and beta-cell function.
- Measured glucose-stimulated calcium (Ca2+) responses to evaluate cell viability and function.
Main Results:
- The hydrodynamic trap design enhanced media flow through islets while limiting shear stress on the perimeter.
- Islets cultured in the device exhibited improved endothelial cell morphology.
- Glucose-stimulated calcium responses in beta cells remained unaffected, indicating preserved function.
Conclusions:
- The novel microfluidic device successfully maintains pancreatic islet endothelial cell health in vitro.
- This technology provides a new tool for studying islet cell interactions and improving islet quality for transplantation.
- The device can prime islets, potentially enhancing outcomes for Type 1 diabetes treatment.

